Rachel Osborn
Obstetrics & Gynecology · Flower Mound, TXNPI 1578793311
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.1% of the total across 312 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations.
Across 312 payments — averaging $16.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Currax Pharmaceuticals LLC$637
- Astellas Pharma US Inc$466
- Mayne Pharma Commercial LLC$349
- Millicent US Inc$251
- Organon$236
- plus $2K from 32 others
What the payments were for
- Food & beverage$4,89196%
- Education$2014%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 81 | $1,040 |
| Currax Pharmaceuticals LLC | 54 | $637 |
| Astellas Pharma US Inc | 16 | $466 |
| Mayne Pharma Commercial LLC | 16 | $349 |
| Millicent US Inc | 12 | $251 |
| Organon | 13 | $236 |
| Shield Therapeutics Inc | 6 | $228 |
| Pfizer | 11 | $215 |
| Roche Diagnostics Corporation | 20 | $200 |
| Endo Pharmaceuticals Inc. | 8 | $131 |
| Hologic Sales And Service, LLC | 1 | $107 |
| Vivus LLC | 8 | $94 |
| Therapeuticsmd, Inc. | 6 | $89 |
| Bayer | 4 | $79 |
| Novo Nordisk | 5 | $78 |
| Idorsia Pharmaceuticals US Inc | 4 | $71 |
| Avion Pharmaceuticals | 4 | $69 |
| Sumitomo Pharma America, Inc. | 3 | $62 |
| Virtus Pharmaceuticals LLC | 3 | $60 |
| Evofem Biosciences, Inc. | 4 | $60 |
| Biogen | 3 | $57 |
| Coopersurgical, Inc. | 3 | $55 |
| Exeltis, USA Inc. | 3 | $54 |
| Exact Sciences | 3 | $49 |
| Agile Therapeutics, Inc. | 3 | $47 |
| Merck | 3 | $43 |
| Myriad Women's Health, Inc. | 1 | $36 |
| Avanos Medical | 1 | $33 |
| Mylan Pharmaceuticals Inc. | 2 | $32 |
| AMAG Pharmaceuticals, Inc. | 2 | $27 |
| Lupin Inc. | 2 | $24 |
| Molnlycke Health Care US, LLC | 1 | $22 |
| Mycovia Pharmaceuticals, Inc. | 1 | $20 |
| Duchesnay USA Incorporated | 1 | $17 |
| Boston Scientific | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Eisai Inc. | 1 | $13 |
| Mission Pharmacal Company | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,091 in reported general payments places this provider in the 85th percentile of 3,099 obstetrics & gynecology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 22 | $854 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Flower Mound
- Caren ReavesFlower Mound$231K
- Laura FingerFlower Mound$47K
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.